Department of Pediatrics and Neonatology, Cloudnine Hospital, Gurgaon, Haryana, India.
Department of Pediatrics and Neonatology, Cloudnine Hospital, Gurgaon, Haryana, India
BMJ Case Rep. 2021 Jan 27;14(1):e239169. doi: 10.1136/bcr-2020-239169.
About 10% of term neonates present with respiratory distress at birth. The most common aetiologies include transient tachypnoea of the newborn, pneumonia and meconium aspiration syndrome (MAS). Hyaline membrane disease (HMD) in a term infant occurs either as primary HMD, secondary surfactant deficiency or congenital surfactant dysfunction. A detailed history supported with appropriate radiological and laboratory investigations can help a clinician reach a diagnosis. We report a case of surfactant dysfunction disorder which presented as severe MAS and persistent pulmonary hypertension of the newborn. In the infant described, the significant history of a sibling death with severe neonatal respiratory disease led us to think of diffuse developmental lung diseases especially surfactant dysfunction syndromes. Exome sequencing detected a heterozygous missense variation in exon 21 of the ATP binding cassette protein member 3 () gene. Based on the clinical picture supported with the exome sequencing, a diagnosis of surfactant dysfunction disorder (ABCA3 deficiency) was confirmed.
大约 10%的足月新生儿在出生时会出现呼吸窘迫。最常见的病因包括新生儿暂时性呼吸急促、肺炎和胎粪吸入综合征(MAS)。足月婴儿的透明膜病(HMD)要么是原发性 HMD,要么是继发于表面活性剂缺乏症,要么是先天性表面活性剂功能障碍。详细的病史并结合适当的影像学和实验室检查有助于临床医生做出诊断。我们报告了一例表面活性剂功能障碍疾病,其表现为严重的 MAS 和新生儿持续性肺动脉高压。在描述的婴儿中,兄弟姐妹死于严重新生儿呼吸疾病的重要病史使我们想到弥漫性发育性肺疾病,特别是表面活性剂功能障碍综合征。外显子组测序在 ATP 结合盒蛋白成员 3(ABCA3)基因的外显子 21 中检测到杂合错义变异。基于外显子组测序支持的临床图像,确诊为表面活性剂功能障碍疾病(ABCA3 缺乏症)。